Skip to content

Quality of Life With Arcoxia in Women With Dysmenorrhea (0663-094)

Quality of Life With Arcoxia in Women With Dysmenorrhea

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00380627
Enrollment
337
Registered
2006-09-26
Start date
2005-09-01
Completion date
2006-01-31
Last updated
2024-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Brief summary

Allow gynecologists to gain experience with arcoxia for treatment of dysmenorrhea.

Interventions

Sponsors

Organon and Co
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

* Healthy women older than 18 years old and younger than 25 years old * Voluntary agreement to participate in the study and signature of informed consent * Women with clinical diagnosis of dysmenorrhea

Exclusion criteria

* Diagnosis of secondary dysmenorrhea due to: endometriosis, adenomyosis, malformations of Muller's conducts, uterine fibromyomas, ovarian cystic, pelvic varicocoele, inflammatory pelvic disease, adherences, intrauterine devices, cervical channel stenosis, etc. * Patients with diagnosis of acute inflammatory abdomen * Patients with diagnosis of congestive heart disease, stroke (1 year), unstable angina, and history of myocardial infarction * Women auto prescribing rescue medication for dysmenorrheal pain during the study * Women with a diagnosis of mild dysmenorrhea

Design outcomes

Primary

MeasureTime frame
Perception of menstrual pain, through the analog verbal scale during three days.

Secondary

MeasureTime frame
Quality of life measures during three days.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026